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Background: The purpose of this study was to examine malaria testing practices and preferences in Bo, Sierra
Leone, and to ascertain interest in and willingness to take a home-based rapid diagnostic test administered by
a community health volunteer (CHV) or a trained family member rather than travelling to a clinical facility for
laboratory-based testing.
Methods: A population-based, cross-sectional survey of 667 randomly-sampled rural households and 157 urban
households was conducted in December 2013 and January 2014.
Results: Among rural residents, 69% preferred a self/family- or CHV-conducted home-based malaria test and 20%
preferred a laboratory-based test (with others indicating no preference). Among urban residents, these numbers were
38% and 44%, respectively. If offered a home-based test, 28% of rural residents would prefer a self/family-conducted
test and 68% would prefer a CHV-assisted test. For urban residents, these numbers were 21% and 77%. In total, 36% of
rural and 63% of urban residents reported usually taking a diagnostic test to confirm suspected malaria. The most
common reasons for not seeking malaria testing were the cost of testing, waiting to see if the fever resolved on its
own, and not wanting to travel to a clinical facility for a test. In total, 32% of rural and 27% of urban participants were
very confident they could perform a malaria test on themselves or a family member without assistance, 50% of rural
and 62% of urban participants were very confident they could perform a test after training, and 56% of rural and 33%
of urban participants said they would pay more for a home-based test than a laboratory-based test.
Conclusion: Expanding community case management of malaria to include home testing by CHVs and family
members may increase the proportion of individuals with febrile illnesses who confirm a positive diagnosis prior to
initiating treatment.
Keywords: Malaria, Rapid diagnostic test, Diagnostic test kits, Community health services, Community health worker,
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Presumptive treatment of suspected cases of malaria
based on symptoms is common in many endemic areas.
In Bo, Sierra Leone, more than half of adults who think
they have malaria make presumptive self-diagnoses and
then treat at home, usually with herbs or with pharma-
ceuticals purchased without prescriptions in local mar-
kets [1]. The 2013 Malaria Indicator Survey in Sierra
Leone found that 29% of urban children and 41% of* Correspondence: kjacobse@gmu.edu
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unless otherwise stated.rural children were not taken to a healthcare facility
when they had fevers [2]. These statistics indicate a high
rate of malaria treatment without testing. Treating sus-
pected malaria without first confirming the presence of
Plasmodium parasites may lead to a variety of negative
individual and community health outcomes due to the
misuse of anti-parasitic medications, money wasted on
ineffective or unnecessary treatments, and delayed ther-
apy for the actual cause of the fever when the illness is
not due to malaria [3]. The World Health Organization
and global health partnerships recommend the use of
diagnostic testing to avoid unnecessary treatment [4].
Initiatives such as ‘test-treat-track’ promote testing allntral. This is an Open Access article distributed under the terms of the Creative
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malarial drugs only those who have a positive malaria
test result, and tracking progress toward malaria control
through health surveillance systems [5].
Two main types of malaria tests are currently available,
microscopy and rapid diagnostic tests (RDTs). Micro-
scopic diagnosis is based on visualizing Plasmodium par-
asites in stained and magnified blood smears. Although
microscopy is still considered the gold standard for mal-
aria testing because it shows the actual presence or ab-
sence of the parasites and allows the parasite load to be
quantified [6], microscopes are usually only available at
clinical laboratories. Microscopy is also dependent on
the skill of the laboratory technician, and the sensitivity
and specificity of the test may vary considerably depend-
ing on the person performing the examination [6,7].
RDTs do not visualize the parasite but instead detect
antigens present in a small sample of blood applied to a
test strip [6,7]. Within about five to 20 minutes of apply-
ing the blood of a person with malaria to a test strip,
one or more lines will appear in the window of the test
kit indicating if parasitic antigens have been detected
[6,7]. One line usually indicates a negative test result,
and two (or more) lines indicate the presence of the
antigen [6]. The results may also indicate an invalid re-
sult, which would require the test to be re-administered
with a new kit. RDTs are a type of point-of-care test
(POCT) or point-of-need test [8]. While RDTs are most
often used at clinical facilities, they can also be used in
home and community settings by community health
workers (CHWs) and community health volunteers
(CHVs). POCTs are useful when they are cost-effective
and accurate tools for providing rapid diagnostic results
[8]. Studies in a variety of settings have demonstrated
that malaria RDTs have adequately high sensitivity and
specificity [6] and can be cost-effective when compared
to microscopy [9-12].
Although diagnosis prior to treatment is strongly en-
couraged by clinical guidelines, there are a variety of fac-
tors that limit access to and uptake of malaria testing.
Cultural and community beliefs about blood and percep-
tions of healthcare providers may discourage testing
[13], lower-income households may not be able to afford
testing or may not prioritize testing when budgeting for
healthcare expenses [3,14], and rural residents may delay
seeking care from the formal medical system because of
the costs and time associated with travelling to a health-
care facility [15,16]. The lack of physical or geographical
access to testing is one that can be at least partly ad-
dressed by programmes offering community case man-
agement (CCM) of malaria. CCM may also overcome
some cultural and economic barriers [4,17].
CCM programmes empower CHWs and CHVs to offer
basic, low-cost healthcare services to households thatmight not otherwise have routine access to medical as-
sistance. CHWs and CHVs participating in CCM pro-
grammes for malaria perform two key functions: using
RDTs to confirm suspected malaria cases and then dis-
pensing anti-malarial drugs to those who test positive
for malaria with an RDT [18]. The RDT kits used by
CHWs and CHVs generally include disposable gloves, al-
cohol swabs, a lancet for drawing a small amount of
blood, the test kit itself, any buffer solutions necessary
for the test, and a small container for safely disposing of
the lancet and other hazardous materials [19]. CHWs
and CHVs also maintain stocks of commonly needed
medications. The ability to use RDTs outside of a
laboratory-based setting may increase the number of fe-
brile persons willing to take a malaria test.
The purpose of this study was to use a cross-sectional
population-based sampling approach to examine malaria
testing practices, attitudes towards malaria testing, and
preferences for testing location in rural and urban Bo,
Sierra Leone.
Methods
Study area
This study was conducted in the city of Bo, Sierra
Leone’s second largest urban area, and in surrounding
rural areas within the Bo District. Sierra Leone is located
on the coast of West Africa, and Bo District is located in
the nation’s Southern Province. Falciparum malaria is
endemic in Sierra Leone, and the country has one of the
highest prevalence rates of malaria in the world [4].
Malaria diagnosis (usually through microscopy rather
than RDTs) and artemisinin-based combination therapy
(ACT) are available free to users of all ages from public
providers [4]. There are few healthcare facilities in rural
areas, but the city of Bo is home to a diversity of public
and private outpatient clinics and several hospitals offer-
ing both inpatient and outpatient services [20,21].
Study population
In 2009, Mercy Hospital Research Laboratory (MHRL)
used a participatory geographic information system
(GIS) process to map the entire city of Bo, including the
locations of all residential, public and commercial struc-
tures [22]. The GIS has been regularly updated since
then. This database enabled MHRL to use a geography-
based sampling method to recruit households from Bo
city for this study. A two-stage cluster (neighbourhood-
based) sampling method was used to identify urban par-
ticipants. First, seven of 68 sections (neighbourhoods) in
the city of Bo were randomly sampled, and then 30
households from each of those seven sections were ran-
domly sampled for participation. In the rural areas, 23
rural communities (villages) were randomly sampled for
participation from a list of the 1,266 villages in Bo
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cruit participants. When fewer than 30 households were
located within the community, interviewers visited resi-
dences at the periphery of the villages until they had
contacted 30 households. In total, 824 of the 900 (91.6%)
contacted households participated in the study, includ-
ing 667 of 690 (96.7%) rural households and 157 of 210
(74.8%) urban households.
In each of the 824 participating households, one adult
representative (age 18 or older) was asked to participate
in a study of attitudes and practices related to malaria
testing. The interviewers preferentially recruited house-
hold members who said they were febrile at the time of
data collection. In both the urban and rural areas, the
interviewers alternated between asking to interview a fe-
male household member and requesting an interview
with a male household member. If an adult of the pre-
ferred gender was not available, a household member of
the opposite gender was interviewed instead. Responses
to interviewer questions were recorded in an OpenData-
Kit questionnaire installed on smartphones. All inter-
views were completed between 14 December, 2013 and
31 January, 2014.Questionnaire
Each participant was asked whether he or she was cur-
rently febrile or without fever. Based on this response,
the next questions related to either the current fever or
to the most recent febrile illness the participant had ex-
perienced. The first set of questions asked whether a
diagnostic test had been performed to determine the
cause of the fever. Participants who did not complete a
diagnostic test during the current or most recent febrile
illness were asked a series of yes/no questions about
their reasons for not seeking a microbiologically-
confirmed diagnosis. The next set of questions asked
whether the participant consulted a doctor or other
healthcare professional about the fever and, if so, asked
about the clinician’s recommendations for testing. Par-
ticipants were asked about their attitudes about home-
based self-testing, CHV-assisted home-based testing and
laboratory-based malaria testing. Data were also col-
lected about demographics, socio-economic status and
self-rated quality of life.Ethical considerations
The study was approved by the institutional review
boards of Njala University, George Mason University,
the Liverpool School of Tropical Medicine, the US Naval
Research Laboratory, and the Office of the Sierra Leone
Ethics and Scientific Review Committee (SLESRC). Par-
ticipation was voluntary, and no incentives or compensa-
tion for participation were provided. All participantsprovided a thumbprint as documentation of their in-
formed consent.
Analysis
The primary variable of interest for this analysis was a
preference for home-based testing, whether conducted
by self/family or by a CHV, over laboratory-based testing
for suspected cases of malaria. Participants who an-
swered both the “self/family vs. laboratory” and “CHV
vs. laboratory” questions with a preference for home-
based testing were considered to have a strong prefer-
ence for home-based testing, and participants who
answered both of these questions with a preference for
laboratory-based testing were considered to have a
strong preference for laboratory-based testing. Partici-
pants indicating no preference, those who would not
take the test at either venue, and those who preferred
home-based testing for one of the paired-comparison
questions and laboratory-based testing for the other
were not considered to have a strong preference for
home-based or laboratory-based testing and were ex-
cluded from the analyses that focused on only partici-
pants with consistent preference for one of the two
testing settings. Participant characteristics and testing
preferences were compared using two-sided Pearson’s
Chi-squared tests. Because there were significant differ-
ences in the characteristics of rural and urban partici-
pants, most analyses were conducted separately by
location. The statistical analysis was conducted using
SPSS version 22 with a significance level of α = 0.05.
Results
The age and gender distributions of rural and urban par-
ticipants were similar (Table 1). The mean age of the
participants was 40.9 years (standard deviation: 18.3),
with half of the participants male and half female, as per
the study design. However, there were significant socio-
economic differences by location, with rural residents
reporting lower levels of education (p < 0.001), lower
rates of literacy (p < 0.001) and less ownership of mobile
phones (p < 0.001). Rural residents were also more likely
than urban residents to rate their quality of life and their
health status as poor (p < 0.01). Because of these signifi-
cant differences by location, all analyses were conducted
separately for rural and urban participants.
Participant answers to the paired-comparison ques-
tions about preferred malaria testing location expressed
a significant preference for home-based testing over
laboratory-based testing in rural areas (Table 2). Among
the 660 rural residents who responded to these ques-
tions, 68.8% (n = 454) preferred home-based testing by
self/family or by a CHV over laboratory-based testing;
19.8% (131) preferred laboratory-based testing over
home-based testing; 4.2% (28) rated laboratory-based
Table 1 Characteristics of participants in rural and urban areas (n = 824)
Characteristic Rural (n = 667) Urban (n = 157) 2-sided Chi-squared
test p-valuen % n %
Gender Male 335/667 50.2 77/157 49.0 0.790
Female 332/667 49.8 80/157 51.0
Age (years) 18-29 178/650 27.4 57/157 36.3 0.087
30-49 276/650 42.5 59/157 37.6
≥50 196/650 30.2 41/157 26.1
Years of formal education No formal school 436/665 65.6 93/155 60.0 <0.001
1-7 years 109/665 16.4 8/155 5.2
8-11 years 62/665 9.3 23/155 14.8
≥12 years 58/665 8.7 31/155 20.0
Can read English 172/650 26.5 61/155 39.4 0.001
Can read Arabic 44/655 6.7 24/154 15.6 <0.001
Comfortable reading a newspaper 123/473 26.0 54/116 46.6 <0.001
Owns a mobile phone 208/661 31.5 77/152 50.7 <0.001
Actively involved in a faith-based organization 601/657 91.5 135/145 93.1 0.519
A HCP in Bo is a family member or friend 287/664 43.2 84/154 54.5 0.011
Quality of life over the past four weeks Good or very good 213/666 32.0 50/157 31.8 0.007
Average 241/666 36.2 75/157 47.8
Poor or very poor 212/666 31.8 32/157 20.4
Satisfaction with health over the past four weeks Satisfied or very satisfied 303/667 45.4 86/157 54.8 0.001
Average 162/667 24.3 46/157 29.3
Dissatisfied or very dissatisfied 202/667 30.3 25/157 15.9
Comparison of health status to the average person
of the same age
More healthy 181/667 27.1 56/157 35.7 0.097
About the same 201/667 30.1 44/157 28.0
Less healthy 285/667 42.7 57/157 36.3
HCP: healthcare provider.
The numbers in bold are statistically significant test results (p<0.05).
Table 2 Preferences for malaria test location (n = 824)
Question Home-based
test by
self/family
Home-based
test by a
trained CHV
Laboratory-based test No preference Would not
take the test
either way
Some communities have trained volunteers
who are able to do malaria tests in their
neighbours’ homes. If a community health
volunteer lived in your section, would you
prefer to take a malaria test at a clinical
laboratory or in your home?
Rural – 72.1% (477/662) 24.8% (164/662) 1.7% (11/662) 1.5% (10/662)
Urban – 40.9% (63/154) 58.4% (90/154) 0.6% (1/154) 0.0% (0/154)
Some new malaria tests are designed for self-use.
If you had the option of testing yourself for malaria
at home, would you prefer to take a malaria test
at a clinical laboratory or in your home?
Rural 73.5% (486/661) – 22.5% (149/661) 2.0% (13/661) 2.0% (13/661)
Urban 52.6% (81/154) – 46.1% (71/154) 1.3% (2/154) 0.0% (0/154)
If you were going to take a malaria test while at
home, would you prefer to do the test yourself
(or have a family member help you) or have a
community health volunteer assist you?
Rural 28.1% (186/661) 68.1% (450/661) – 2.0% (13/661) 1.8% (12/661)
Urban 21.3% (33/155) 76.8% (119/155) – 0.6% (1/155) 1.3% (2/155)
Note: This table excludes participants who did not provide a response to either question.
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than self/family testing; 2.6% (17) rated laboratory-based
testing as better than self/family testing but worse than
CHV-assisted testing; and 4.5% (30) indicated no prefer-
ence or said they would decline all of these testing options.
Among the 154 urban residents who responded, 38.3%
(59) preferred home-based testing over laboratory-based
testing and 43.5% (67) preferred laboratory-based testing
over home-based testing. In both rural and urban areas,
CHV-assisted home-based testing was preferred over self/
family-conducted home-based testing. In rural areas,
68.1% (450) preferred CHV-assisted testing compared to
only 28.1% (186) who preferred self/family-conducted test-
ing. In urban areas, 76.8% (119) preferred testing by a
CHV and 21.3% (33) preferred testing by self or a family
member.
In total, 47.8% (n = 308/644) of the rural participants
and 75.3% (116/154) of the urban participants said they
usually consult with a healthcare provider about sus-
pected malaria (Table 3). Among rural and urban partic-
ipants, 37.1% (247/666) and 55.8% (87/156), respectively,
reported having had a diagnostic test to determine the
cause of the most recent febrile illness, 35.6% (231/649)
and 62.7% (94/150) reported usually taking a diagnostic
test to confirm suspected malaria, and 89.5% (578/646)
and 88.2% (125/153) said that they usually bought medi-
cations or herbs to treat malaria without first consulting
with a healthcare provider.
Rates of preference for home-based testing and for
laboratory-based testing were similar in rural and urban
areas by gender (p = 0.488 and 0.713, respectively), age
(p = 0.670 and 0.605), and years of education (p = 0.094
and 0.039, with urban residents with more education
more likely to prefer laboratory-based testing). There
was no difference in testing location preference by fever
status at the time of the survey (p = 0.929). Among rural
residents, a preference for home-based testing over
laboratory-testing was especially high among those who
were not comfortable reading a newspaper (p = 0.006),
those not owning a mobile phone (p = 0.031), those who
reported usually self-treating suspected malaria rather
than consulting with a healthcare provider (p < 0.001),
and those who believe that adult fevers are always
caused by malaria (p < 0.001). Among urban residents, a
preference for home-based testing over laboratory-
testing was especially high among those who were able
to read English (p = 0.003) and comfortable reading a
newspaper (p = 0.001), those who did not usually take a
diagnostic test to confirm suspected malaria (p < 0.001),
and those who reported being very confident about
their ability to perform a malaria self-test after training
(p < 0.001). Those who indicated a preference for
home-based testing were significantly more likely than
those preferring laboratory-based testing to say thatthey would be willing to pay extra for the option of a home-
based test, and this was found in both rural (p < 0.001) and
urban (p = 0.005) areas.
In total, 31.7% (198/625) of rural participants and
27.3% (42/154) of urban participants said they were very
confident they could perform a malaria test on them-
selves or a family member without assistance. Among
those indicating a preference for self/family-conducted
home-based testing over CHV-assisted testing, 74.2%
(138/186) of rural residents and 33.3% (11/33) of urban
residents were very confident in their ability to conduct
a test on themselves or a family member. Reported self-
confidence was lower among participants indicating a
preference for a home-based tested administered by a
CHV rather than self/family, with only 14.0% (60/428) of
rural residents and 26.1% (31/119) or urban residents
with this preference saying they were very confident in
their self-testing ability. In total, 50.1% (314/627) of the
rural participants were very confident they could per-
form a test if they had been trained on how to use a test
kit, including 88.7% (165/186) with a preference for
self/family-conducted home-based testing and 34.0%
(146/430) with a preference for testing administered by
a CHV. Among the urban participants, 61.7% (95/154)
were very confident in their testing abilities if trained, in-
cluding 75.8% (25/33) with a preference for self/family-
conducted home-based testing and 58.8% (70/119) with a
preference for testing administered by a CHV.
Among the 488 participants who did not seek a diag-
nostic test for their most recent febrile illness, 330
(67.6%) preferred a home-based test and 95 (19.5%) pre-
ferred a laboratory-based test (Table 4). The most com-
mon reasons for not seeking testing were similar for
both testing preference and location groups: not wanting
to spend money on the test (68.0%), waiting to see if the
fever resolved within a few days (45.0%), not wanting to
travel to a clinical facility for a test (41.0%) and assuming
that a formal diagnosis was not needed because adults
could presumptively diagnose the cause of the fever
(37.4%). Those with a preference for home-based test-
ing were more likely than those with a preference for
laboratory-based testing to say that they did not need a
test because they already knew the cause of the fever
(p = 0.025). Urban non-testers were significantly more
likely than rural non-testers to assume that they already
knew the cause of the fever (p = <0.001) and to say that
they did not want to wait for test results (p = 0.010). A
dislike of blood draws was not a common reason not to
seek testing (15.6%).
Discussion
The participants in this study, especially those living in
rural areas, expressed a high level of interest in home-
based testing for malaria. A recent systematic review of
Table 3 Characteristics of participants who indicated a consistent preference for home-based testing (by self/family or CHV) or laboratory-based testing
Characteristic Rural Urban
Home-based testing
preference (n = 454)
Laboratory-based
testing preference
(n = 131)
2-sided Chi-squared
test p-value
Home-based testing
preference (n = 59)
Laboratory-based
testing preference
(n = 67)
2-sided Chi-squared
test p-value
Febrile at the time of the survey 52.4 (238/454) 55.7 (73/131) 0.505 39.0 (23/59) 40.3 (27/67) 0.880
Usually consults with a healthcare provider about suspected
malaria
45.5 (201/442) 56.0 (70/125) 0.038 71.2 (42/59) 78.8 (52/66) 0.326
A healthcare provider recommended a diagnostic test during
the most recent consultation for a fever
55.2 (232/420) 54.2 (64/118) 0.847 62.7 (37/59) 80.0 (52/65) 0.033
Had a diagnostic test to determine the cause of most recent
febrile illness
34.0 (154/454) 45.8 (60/131) 0.014 47.5 (28/59) 63.6 (42/66) 0.069
Usually takes a diagnostic test to confirm suspected malaria 32.5 (145/446) 43.2 (54/125) 0.027 39.7 (23/58) 77.8 (49/63) <0.001
Usually buys medicines to treat malaria without first consulting a
healthcare provider
82.7 (369/446) 64.3 (83/129) <0.001 89.8 (53/59) 82.1 (55/67) 0.215
Willing to pay more for a home-based test than a laboratory-
based test
63.2 (287/454) 25.4 (33/130) <0.001 44.1 (26/59) 20.9 (14/67) 0.005
Belief about how often adult fevers
in the community are due to malaria
Always 30.2 (137/454) 11.5 (15/131) <0.001 35.6 (21/59) 20.9 (14/67) 0.160
Most of the time 27.3 (124/454) 62.6 (82/161) 39.0 (23/59) 52.2 (35/67)
Sometimes 35.5 (161/454) 20.6 (27/131) 25.4 (15/59) 26.9 (18/67)
Rarely or never 7.0 (32/454) 5.3 (7/131) 0.0 (0/0) 0.0 (0/0)
Confidence in ability to perform a
malaria test on self without assistance
Very confident 36.5 (165/452) 26.1 (29/111) 0.034 45.8 (27/59) 16.4 (11/67) <0.001
Somewhat confident 17.7 (80/452) 14.4 (16/111) 45.8 (27/59) 26.9 (18/67)
Not at all confident 45.8 (207/452) 59.5 (66/111) 8.5 (5/59) 56.7 (38/67)
Confidence in ability to perform a
malaria test if trained on how to use
a test kit
Very confident 51.9 (235/453) 43.2 (48/111) 0.005 83.1 (49/59) 37.3 (25/67) <0.001
Somewhat confident 15.5 (70/453) 28.8 (32/111) 13.6 (8/59) 23.9 (16/67)
Not at all confident 32.7 (148/453) 27.9 (31/111) 3.4 (2/59) 38.8 (26/67)
The numbers in bold are statistically significant test results (p<0.05).
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Table 4 Reasons for not seeking diagnostic testing for the last febrile illness
Characteristic Home-based (by self/family or CHV)
testing preference (n = 330)
Laboratory-based testing
preference (n = 95)
Rural (n = 299) Urban (n = 31) Rural (n = 71) Urban (n = 24)
Did not want to spend money on the test 64.4 (192/298) 71.0 (22/31) 72.9 (51/70) 82.6 (19/23)
Wanted to wait a few days to see if the fever went away 42.4 (126/297) 63.3 (19/30) 32.8 (22/67) 52.4 (11/21)
Did not want to travel to a laboratory 41.9 (124/296) 54.8 (17/31) 22.5 (16/71) 60.9 (14/23)
Did not need a test because already knew the cause of the fever 34.5 (102/296) 83.9 (26/31) 18.6 (13/70) 52.4 (11/21)
A doctor or other healthcare provider did not recommend a test 27.2 (81/298) 25.8 (8/31) 33.3 (23/69) 31.6 (6/19)
Did not want to have to wait for the test results 23.5 (70/298) 35.5 (11/31) 16.9 (12/71) 56.5 (13/23)
Does not like blood draws 14.2 (42/296) 16.1 (5/31) 11.4 (8/70) 34.8 (8/23)
Note: This table presents results for the 488 (59.4%) adults who reported not seeking microbiological diagnosis of the cause of the most recent febrile illness and
then indicated a preference for home-based or laboratory-based testing (n = 425).
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that trained CHWs could successfully conduct RDTs
and use the test results to recommend appropriate treat-
ment [18]. Studies in which community members are
part of the selection process for CHVs are particularly
successful in increasing access to testing [10,17]. The
primary concerns about CCM of malaria are some
CHWs recommending anti-malarial medications follow-
ing negative malaria tests and many febrile individuals
not following through on recommended clinical consul-
tations after negative test results [18,23]. Few studies
have examined the use of home-based RDTs conducted
by family members trained and supervised by CHVs ra-
ther than by the CHVs themselves, but this study sug-
gested an openness to self/family testing in addition to
CHV testing. Self/family testing with RDTs pre-
purchased by the household might increase malaria-
testing access in small farming villages that are located
farther than easy walking distance from a community
with a trained CHV.
Home-based malaria testing, often with the assistance
of a CHV, has been successfully implemented in other
sub-Saharan African communities. In the rural Iganga
district of Uganda, community members expressed a
high level of trust in CHVs who were trained to conduct
malaria RDTs and to recommend appropriate malaria
treatment [24]. In villages in the South Kordofan State
of Sudan, the use of CHV-conducted RDTs significantly
increased access to malaria tests and malaria treatment,
especially during the rainy season when travel to a clinic
was often impossible [17]. In two provinces in Zambia,
CHVs had a very high rate of correct recommendations
for malaria treatment or referral to a healthcare facility
after conducting in-home RDTs [10]. Given the substan-
tial interest in home-based malaria testing in rural Bo
district in Sierra Leone, it seems likely that CHVs in
these communities could successfully test and treat mal-
aria in homes, and perhaps even train willing and
confident family members to conduct RDTs in their ownhouseholds, making appropriate referrals for hospital
care when necessary.
The most commonly reported barriers to the uptake
of home-based testing for malaria include concerns
about infection transmission during blood draws [24,25]
and concerns about reliable access to RDTs for home-
based testing use [10,23,26]. Any programme for home-
based testing would need to include clear instructions
about how to safely dispose of lancets and test kits.
CHVs could be encouraged to collect used kits they had
distributed and to ensure that they were processed as
medical waste. Consistent access to RDTs would need to
be supported through community partnerships with
local hospitals and government health officials.
This study in Sierra Leone used a cross-sectional ap-
proach with self-reported answers about febrile status
and testing preferences. Participants were not asked to
try conducting a malaria test on themselves or a family
member, so all answers about willingness to conduct a
test and confidence about the ability to conduct a test
are hypothetical. This willingness-to-test survey will
need to be followed by field tests of RDTs by CHVs and
CHV-trained family members. Should these tests prove
to be acceptable to the community, safe and valid, the
programme could be expanded to include RDTs for
other locally-important infections.
Conclusions
Expanded access to CCM might improve access to diag-
nosis and appropriate, timely and cost-efficient treat-
ment. Existing CHV networks in Sierra Leone could
provide a foundation for intensifying CCM. The success
of home-based testing in these communities would likely
be dependent on (1) a high level of respect for and trust
in new and existing CHVs by the communities they sup-
port; (2) the availability of a strong network of CHVs
who are confident in their own RDT skills and are able
to conduct tests themselves as well as teach others to
conduct tests; (3) sufficient public health resources to
Ranasinghe et al. Malaria Journal  (2015) 14:80 Page 8 of 9support ‘train-the-trainer’ sessions to teach CHVs how
to coach their neighbours through their first self/family
malaria tests; and, (4) a competitive price point for home
test kits when compared to the out-of-pocket costs of
laboratory-based testing.
The possible importance of home-based self-testing
has been highlighted by the recent Ebola outbreak. In
the months after this survey was conducted, hundreds of
cases of Ebola occurred in Bo district [27,28]. Many
clinics and hospitals in Bo closed their doors rather than
risk exposing their staff to the Ebola virus, and others
were forced to temporarily close because of quarantines.
Laboratory-based testing for febrile illnesses became
more difficult to conduct and more costly due to the
need to assume that all biological specimens could be
from a patient with Ebola, even when the most likely
diagnosis was something more common and much less
fatal. Quarantines meant that some CHVs in rural areas
could not travel from their home villages to neighbour-
ing ones or stopped volunteering because they feared
contracting Ebola. Thus, access to routine medical care,
including diagnosis and treatment of common infections
such as malaria, decreased significantly, especially in
rural areas that already had limited access to health ser-
vices. Home-based testing that allows trained individuals
with suspected malaria to test themselves and family
members at home, thus limiting the exposure of others
to their blood, could improve the home-based care that
has become necessary for many households as a result
of the strain Ebola put on the entire healthcare system
of Sierra Leone.
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